Anti-Tumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD-1 to Treat Collagen-Rich Solid Tumors

Investigators reported leukocyte-associated immunoglobulin-like receptor 1 was associated with tumor stroma and was highly expressed by intratumoral myeloid cells in both human tumors and mouse models of cancer.